ADF Awards

The ADF announces various prizes to reward scientists / researchers from the field of dermatological research. In addition to the Paul Langerhans Award for established researchers and the Egon Macher Award for young investigators outstanding works in the field of allergy research (ADF / ECARF Award of European Allergy Research) and oncology (Dermato Oncology Junior Scientist Award) will be honored on the ADF Annual Meetings.

In addition, the 6 best posters will be awarded with a poster prize and 6 travel grants for the next ADF Annual Meeting will be awarded.

For the complete tender texts and the detailed allocation policies please click on the highlighted link.

Please note:
For travel grants, the ADF / ECARF Award for European Allergy Research, the Dermato Oncology Junior Scientist Awards and for the Translational Research Award, a separate application is not necessary. For these prices all abstracts submitted before the deadline will be evaluated.
Submissions for the Paul Langerhans Award and the Egon Macher Award should be made in all cases exclusively in electronic form as one PDF file to the ADF office.
Submission deadline: November 01.

Awards

Translational Research Award (until 2014)

- donated by the Foundation Dermatologikum Hamburg - No donation since 2015!

From 2006 to 2014, the ADF was able to offer two prizes in the field of Translational Research, which were awarded by the Foundation Dermatologikum Hamburg every 2 years.

These prizes will be awarded to researchers in the field of Dermatology who are attempting to transfer insights gained in experimental basic research into clinical applications. Junior scientists who present qualitatively outstanding and innovative work in this field are preferably considered.

Awarded are 2x 2.500,- EUR.

Prize winners have been elected at the annual ADF meeting by an independent jury, which was nominated by the ADF Board every 2 years. The prizes was awarded to first or senior authors who have performed outstanding work in the field of Translational Research.  Work in which a member of the jury is first or senior author were excluded.

All contributions to clinical translation research (poster/oral presentation) that were submitted on time to the ADF Annual Meeting had been considered.

Board of trustees (until 2014):

  • Prof. Dr. Wolf Henning Boehncke (Vorsitz)
  • Prof. Dr. Jens Malte Baron
  • Prof. Dr. Cornelia Mauch
  • Prof. Dr. Kristian Reich (Stiftung Dermatologikum Hamburg)
  • Prof. Dr. Michael Schön
  • Prof. Dr. Detlef Zillikens

Past awardees of the Translational Research Award (until 2014)


2014
A. Stegemann, Münster
Beta-endorphin - an emerging antifibrotic neuropeptide

2014
N. Wagner, Heidelberg
RAGE ligands S100A8/A9 and HMGB1 as prognostic markers in melanoma

2012
J. Stehn, Sydney
Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells

2012
Misa Hirose, Lübeck
Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen

2010
Katja Bieber, Lübeck
Modulation of experimental epidermolysis bullosa acquisita towards an improved phenotype by initiating the production of non-pathogenic autoantibodies

2008
J. S. Kern, Freiburg
Cell therapy restores skin function in an immunocompetent mouse model for dystrophic epidermolysis bullosa

2010
Robert Sabat, Berlin
Interleukin(IL)-22, a T-cell mediator, induces in keratinocytes IL-20, a tissue cell mediator: a novel cascade with major relevance for the pathogenesis of psoriasis The epidermal alterations in psoriasis are mediated by IL-22, but not by other T-cell mediators including IL-17 or IFN-, and are amplified by TNF-alpha.

2008
Thomas Volz, Tübingen
Induction of IL-10 producing suppressor T cells by non-pathogenic gram-negative bacteria clears atopic dermatitis

2006
E. Gaffal, Bonn
Contact hypersensitivity is significantly increased in cannabinoid receptorknockout mice: Evidence for the involvement of the endogenous cannabinoidsystem in the regulation of cutaneous immune responses.

2006
S. Meyer, Regensburg
High-throughput tissue microarray analysis of MTAP expression inmelanocytic skin tumors.